Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta‐analysis
Keiichiro Mori(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Wojciech Krajewski(Wroclaw Medical University), Shoji Kimura(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Wataru Fukuokaya(Jikei University School of Medicine), Satoshi Katayama(Okayama University), Jun Miki(Jikei University School of Medicine), Benjamin Pradère, Masaya Murakami(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Simone Albisinni(University of Rome Tor Vergata), Alessia Cimadamore(University of Udine), Shunsuke Tsuzuki(Jikei University School of Medicine), Jeremy Yuen‐Chun Teoh(Chinese University of Hong Kong), Ekaterina Laukhtina(Sechenov University), Kenta Miki(Jikei University School of Medicine), Shahrokh F. Shariat(Universitätszahnklinik Wien), Marco Moschini(Vita-Salute San Raffaele University), Paweł Rajwa(University College London), Francesco Del Giudice(Sapienza University of Rome), Akihiro Matsukawa(Jikei University School of Medicine)
Cited by 11
Related Papers
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289